1. 635. Efficacy, Pharmacokinetics (PK), and Safety Profile of MEDI3902, an Anti-Pseudomonas aeruginosa Bispecific Human Monoclonal Antibody in Mechanically Ventilated Intensive Care Unit Patients; Results of the Phase 2 EVADE Study Conducted by the Public-Private COMBACTE-MAGNET Consortium in the Innovative Medicines Initiative (IMI) Program. (31st December 2020) Authors: Chastre, Jean; François, Bruno; Bourgeois, Marc; Komnos, Apostolos; Ferrer, Ricard; Rahav, Galia; De Schryver, Nicolas; Lepape, Alain; Koksal, Iftihar; Luyt, Charles-Edouard; Garcia, Miguel Sanchez; Torres, Antoni; Holland, Thomas L; Holland, Thomas L; Ali, Omar; Shoemaker, Kathryn; Ren, Pin; Ruz... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗